Loading...

Urban Clinic Expansion And AI Integration Will Transform Brazilian Healthcare

Published
20 Dec 24
Updated
15 Oct 25
AnalystConsensusTarget's Fair Value
R$55.65
40.0% undervalued intrinsic discount
15 Oct
R$33.40
Loading
1Y
-40.1%
7D
-6.9%

Author's Valuation

R$55.6540.0% undervalued intrinsic discount

AnalystConsensusTarget Fair Value

Shared on15 Oct 25
Fair value Decreased 5.73%

Hapvida Participações e Investimentos saw its analyst price target decrease from R$59.04 to R$55.65. Analysts cited updated assumptions for discount rates, revenue growth, and projected profitability margins.

Shared on15 Sep 25
Fair value Increased 1.91%

Hapvida Participações e Investimentos saw a slight increase in its future P/E ratio, reflecting marginally improved growth expectations, which contributed to a minor upward revision in its consensus analyst price target from R$57.93 to R$59.04. Valuation Changes Summary of Valuation Changes for Hapvida Participações e Investimentos The Consensus Analyst Price Target remained effectively unchanged, moving only marginally from R$57.93 to R$59.04.

Shared on01 May 25
Fair value Decreased 11%

Shared on23 Apr 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on17 Apr 25
Fair value Decreased 2.63%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on09 Apr 25
Fair value Decreased 2.73%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on02 Apr 25
Fair value Decreased 3.59%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on26 Mar 25
Fair value Decreased 2.51%

AnalystConsensusTarget has decreased revenue growth from 10.0% to 8.2% and decreased shares outstanding growth rate from 0.0% to -0.0%.

Shared on19 Mar 25
Fair value Increased 19%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on12 Mar 25
Fair value Decreased 0.042%